Skip to main content

Advertisement

SpringerLink
Log in

Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes

  • Invited Review Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Recently, a number of new minimally invasive image-guided percutaneous ablation treatments, including cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound, laser ablation, and irreversible electroporation have been developed. Several studies have shown the feasibility and safety of these cryoablation therapies for the treatment of benign breast tumors and small invasive breast cancer. Although the complete response rate of cryoablation for breast cancer is reported to be relatively good, most studies enrolled a small number of patients, and so reliable conclusions could not be drawn. In this review, we introduce the mechanisms of action of cryoablation, and summarize the current literature on the efficacy and safety of cryoablation for breast cancer. Cryoablation also induces an immunomodulatory effect, which is an interesting topic of research in the era of immune checkpoint inhibitors. Cryoablation for primary tumor may enhance the treatment effect of immune checkpoint inhibitors in patients with breast cancer. Further investigations of this new therapeutic strategy are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262

    Article  Google Scholar 

  2. Fisher B, Jeong JH, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. New Engl J Med 347:567–575. https://doi.org/10.1056/NEJMoa020128

    Article  PubMed  Google Scholar 

  3. Fleming MM, Holbrook AI, Newell MS (2017) Update on image-guided percutaneous ablation of breast cancer. AJR Am J Roentgenol 208:267–274. https://doi.org/10.2214/AJR.16.17129

    Article  PubMed  Google Scholar 

  4. Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199–208. https://doi.org/10.1038/nrc3672

    Article  CAS  PubMed  Google Scholar 

  5. Yang WL, Addona T, Nair DG et al (2003) Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer 103:360–369. https://doi.org/10.1002/ijc.10822

    Article  CAS  PubMed  Google Scholar 

  6. Alblin RJ, Soanes WA, Gonder MJ (1971) Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate. Cryobiology 8:271–279

    Article  CAS  PubMed  Google Scholar 

  7. Abdo J, Cornell DL, Mittal SK et al (2018) Immunotherapy plus cryotherapy: Potential augmented abscopal effect for advanced cancers. Front Oncol 8:85. https://doi.org/10.3389/fonc.2018.00085

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kumar AV, Patterson SG, Plaza MJ (2019) Abscopal effect following cryoablation of breast cancer. J Vasc Interv Radiol 30:466–469. https://doi.org/10.1016/j.jvir.2018.12.004

    Article  PubMed  Google Scholar 

  9. Sabel MS, Kaufman CS, Whitworth P et al (2004) Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann Surg Oncol 11:542–549. https://doi.org/10.1245/ASO.2004.08.003

    Article  PubMed  Google Scholar 

  10. Simmons RM, Ballman KV, Cox C, ACOSOG Investigators et al (2016) A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol 23:2438–2445. https://doi.org/10.1245/s10434-016-5275-3

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mauri G, Sconfienza LM, Pescatori LC et al (2017) Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis. Eur Radiol 27:3199–3210. https://doi.org/10.1007/s00330-016-4668-9

    Article  PubMed  Google Scholar 

  12. Machida Y, Shimauchi A, Igarashi T, et al (2018) MRI findings after cryoablation of primary breast cancer without surgical resection. Acad Radiol. https://doi.org/10.1016/j.acra.2018.07.012(Epub ahead of print)

    Article  PubMed  Google Scholar 

  13. Pusceddu C, Melis L, Ballicu N et al (2017) Cryoablation of primary breast cancer in patients with metastatic disease: considerations arising from a single-centre data analysis. Biomed Res Int 2017:3839012. https://doi.org/10.1155/2017/3839012

    Article  PubMed  PubMed Central  Google Scholar 

  14. Beji H, Pilleul F, Picard R et al (2018) Percutaneous cryoablation of breast tumours in patients with stable metastatic breast cancer: safety, feasibility and efficacy. Br J Radiol 91:20170500. https://doi.org/10.1259/bjr.20170500

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sabel MS, Nehs MA, Su G et al (2005) Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 90:97–104. https://doi.org/10.1007/s10549-004-3289-1

    Article  CAS  Google Scholar 

  16. Liang S, Niu L, Xu K et al (2017) Tumor cryoablation in combination with natural killer cells therapy and herceptin in patients with HER2-overexpressing recurrent breast cancer. Mol Immunol 92:45–53. https://doi.org/10.1016/j.molimm.2017.10.003

    Article  CAS  PubMed  Google Scholar 

  17. McArthur HL, Diab A, Page DB et al (2016) A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling. Clin Cancer Res 22:5729–5737. https://doi.org/10.1158/1078-0432.CCR-16-0190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Page DB, Yuan J, Redmond D et al (2016) Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy. Cancer Immunol Res 4:835–844. https://doi.org/10.1158/2326-6066.CIR-16-0013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Adams S, Loi S, Toppmeyer D, et al (2018) Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: Cohort B of the Phase 2 KEYNOTE-086 study. Ann Oncol. https://doi.org/10.1093/annonc/mdy518 (Epub ahead of print)

    Article  PubMed  Google Scholar 

  20. Adams S, Schmid P, Rugo HS, et al (2018) Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the Phase 2 KEYNOTE-086 Study. Ann Oncol. https://doi.org/10.1093/annonc/mdy517 (Epub ahead of print)

    Article  PubMed  Google Scholar 

  21. Heery CR, O'Sullivan-Coyne G, Madan RA et al (2017) Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial. Lancet Oncol 18:587–598. https://doi.org/10.1016/S1470-2045(17)30239-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nanda R, Chow LQ, Dees EC et al (2016) Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib KEYNOTE-012 Study. J Clin Oncol 34:2460–2467. https://doi.org/10.1200/JCO.2015.64.8931

    Article  CAS  PubMed  Google Scholar 

  23. Rugo HS, Delord JP, Im SA et al (2018) Safety and antitumor activity of pembrolizumab in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer. Clin Cancer Res 24:2804–2811. https://doi.org/10.1158/1078-0432.CCR-17-3452

    Article  CAS  PubMed  Google Scholar 

  24. Schmid P, Adams S, Rugo HS, IMpassion130 Trial Investigators et al (2018) Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. New Engl J Med 379:2108–2121. https://doi.org/10.1056/NEJMoa1809615

    Article  CAS  PubMed  Google Scholar 

  25. Morin J, Traore A, Dionne G et al (2004) Magnetic resonance-guided percutaneous cryosurgery of breast carcinoma: technique and early clinical results. Can J Surg 47(5):347–351

    PubMed  PubMed Central  Google Scholar 

  26. Pfleiderer SO, Marx C, Camara O et al (2005) Ultrasound-guided, percutaneous cryotherapy of small (%3c or = 15 mm) breast cancers. Invest Radiol 40(7):472–477

    Article  PubMed  Google Scholar 

  27. Pusztaszeri M, Vlastos G, Kinkel K et al (2007) Histopathological study of breast cancer and normal breast tissue after magnetic resonance-guided cryotherapy ablation. Cryobiology 55(1):44–51. https://doi.org/10.1016/j.cryobiol.2007.05.002

    Article  PubMed  Google Scholar 

  28. Littrup PJ, Jallad B, Chandiwala-Mody P et al (2009) Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol 20(10):1329–1341. https://doi.org/10.1016/j.jvir.2009.06.029

    Article  PubMed  Google Scholar 

  29. Manenti G, Scarano AL, Pistolese CA, et al. (2013) Subclinical breast cancer: minimally invasive approaches. Our experience with percutaneous radiofrequency ablation vs. cryotherapy. Breast Care (Basel) 8(5):356–360. doi:10.1159/000355707

  30. Pusceddu C, Sotgia B, Amucano G et al (2014) Breast cryoablation in patients with bone metastatic breast cancer. J Vasc Interv Radiol 25(8):1225–1232. https://doi.org/10.1016/j.jvir.2014.05.001

    Article  PubMed  Google Scholar 

  31. Gajda MR, Mireskandari M, Baltzer PA, et al. (2014) Breast pathology after cryotherapy. Histological regression of breast cancer after cryotherapy. Pol J Pathol 65(1):20–28

    Article  PubMed  Google Scholar 

  32. Cazzato RL, de Lara CT, Buy X et al (2015) Single-centre experience with percutaneous cryoablation of breast cancer in 23 consecutive non-surgical patients. Cardiovasc Intervent Radiol 38(5):1237–1243. https://doi.org/10.1007/s00270-015-1181-5

    Article  PubMed  Google Scholar 

  33. Poplack SP, Levine GM, Henry L et al (2015) A pilot study of ultrasound-guided cryoablation of invasive ductal carcinomas up to 15 mm with MRI follow-up and subsequent surgical resection. AJR Am J Roentgenol 204(5):1100–1108. https://doi.org/10.2214/AJR.13.12325

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgery, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Masahiro Takada & Masakazu Toi

Authors
  1. Masahiro Takada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masakazu Toi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masahiro Takada.

Ethics declarations

Conflict of interest

M. Takada has received honoraria from Chugai, AstraZeneca, Kyowa Hakko Kirin, and Eisai; and has received a research Grant from Eisai. M. Toi has no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takada, M., Toi, M. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Int J Clin Oncol 24, 608–613 (2019). https://doi.org/10.1007/s10147-019-01448-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-019-01448-4

Keywords

Search

Navigation